United States · FDA National Drug Code directory
SHISEIDO FUTURE LX TOTAL RADIANCE FOUNDATION E Rose 2
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58411-337_47aac3f6-8b7d-10fb-e063-6394a90aafa0
- Product NDC
- 58411-337
- Form
- CREAM
- Composition / generic term
- OCTINOXATE
- Labeler
- SHISEIDO AMERICAS CORPORATION
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20170801
- Source listing expiry
- 20271231
Source-listed ingredients
- OCTINOXATE — 1832 mg/30mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 JAR in 1 CARTON (58411-337-50) / 30 mL in 1 JAR · 58411-337-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →